Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018

世界の神経修復・神経再生市場:異種移植片、神経調節、手術など

◆タイトル:Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018
◆商品コード:BT 2105
◆調査・発行会社:MarketsandMarkets
◆発行日:2013年9月
◆ページ数:229
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User(~5名)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate licence(社内共有可) USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界の神経修復・神経再生市場:異種移植片、神経調節、手術など"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場概観、市場の成長要因、阻害要因、市場の機会と課題、市場の動態、製品別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業(ベンダー)分析等の情報をお届けいたします。

The nerve repair and regeneration market was worth $4.1 billion in 2012 and is expected to grow at a CAGR of 11.5% in the next five years, primarily due to technological advancements and favorable reimbursement policies. The market is expected to witness a high growth in nerve grafting and neuromodulation segments, as they offer effective solutions for peripheral nerve repair and chronic pain, incontinence, heart failure, headache, depression, and epilepsy. Moreover, there are certain devices in clinical trials for newer applications; for instance, deep brain stimulation for Alzheimer’s and depression, and vagus nerve stimulation for heart failure. Novel therapies (such as stem cell therapy) and emerging markets provide huge growth opportunities. However, the major challenges faced by the industry are donor site morbidity and inadequate nerve regenerationby conduits. The neuromodulation market is expected to reach $7.8 billion by 2018.

The peripheral nerve repair segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such asSpinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS),Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS).

A number of factors such as the rapidly aging population, growing number of peripheral nerve injuries and associated diseases like Alzheimer’s, epilepsy, and Parkinson’s are the major reasons for the growth of this market. According to a recent study, around 87% of peripheral nerve injuries are resulted from trauma; the U.S. accounts for around 40% of the global peripheral nerve repair surgeries. According to the International Neurostimulation Society, about 40 million to 50 million patients worldwide suffer from epilepsy and 1.5 million people suffer from Parkinson’s in the U.S. alone. Moreover,treatment for tinnitus represents one of the emerging applications in this market. According to the American Tinnitus Association, about 50 million people suffer from this disease in the U.S. alone.

Major players in the peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.).

Scope of the Report
The global nerve repair and regeneration market has been segmented based on surgery andproducts.Both of these markets are broken down into segments and sub-segments, providing exhaustive value and volume analysis for the years 2011, 2012, 2013, and forecast to 2018. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World), to provide in-depth information on the global scenario.

Global Nerve Repair and Regeneration Market

Nerve Repair and Regeneration Market, by Surgery

Direct Nerve Repair/Neurorraphy
Perineural repair
Epineural repair
Group Fascicular Repair
Nerve Grafting
Autografts
Allografts
Xenografts
Stem cell therapy
Neurostimulation/Neuromodulation surgery

2. Nerve Repair and Regeneration Market, by Products
Nerve repair, by Biomaterials

Nerve Conduits
Nerve Protectors
Nerve Wraps
Nerve Connectors

Nerve repair, by Neurostimulation/Neuromodulation

Internal Neurostimulation
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electrical Stimulation

External Neurostimulation

Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation

3. Global Nerve Repair and Regeneration Market, by Geography

North America
Europe
Asia
ROW (Africa, LATAM, Middle-East, andPacific countries)

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 20)
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Key Data Points From Primary Sources
1.6.4 Key Data Points From Secondary Sources
1.6.5 Assumptions

2 Executive Summary (Page No. – 33)

3 Market Overview (Page No. – 37)
3.1 Introduction
3.2 Market Segmentation
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Increasing Incidence Of Peripheral Nerve Injuries & Neurological Disorders To Propel Market Growth
3.3.1.2 Technological Advancements In Nerve Repair To Boost The Market
3.3.1.3 Favorable Reimbursement Policies Encourage The Product Usage
3.3.1.4 Expanded Target Applications And New Indications Are Expected To Stimulate The Growth Of Neuromodulation Devices
3.3.2 Restraints
3.3.2.1 Lack Of Surgeons And Patient Awareness To Hamper The Growth
3.3.2.2 Lack Of Trained Professionals To Pose A Negative Impact On The Market Growth
3.3.3 Opportunities
3.3.3.1 Novel Therapies Such As Use Of Stem Cells
3.3.3.2 Emerging Markets
3.3.4 Challenges
3.3.4.1 Donor Site Morbidity
3.3.4.2 Inadequate Nerve Regeneration By Conduits
3.4 Regulations For Nerve Repair And Regeneration Products
3.4.1 Regulations For Humanitarian Use Devices (Hud)
3.4.2 Regulations For Electrically Powered Devices
3.5 Strategic Benchmarking
3.5.1 Agreement Of Alafair Biosciences With University Of Texas
3.5.2 Acquisition Of Synovis Life Technologies, Inc. By Baxter International, Inc.
3.5.3 Acquisition Of Intelect Medical, Inc. By Boston Scientific Corporation 47
3.5.4 Agreement Of Cyberonics, Inc. With Cerbomed, Gmbh
3.5.5 New Product Launch By Polyganics
3.6 Market Share Analysis
3.6.1 Neuromodulation Market
3.6.1.1 Global
3.6.1.2 North America
3.6.1.3 Europe
3.6.1.4 Asia
3.6.2 Peripheral Nerve Repair Market
3.6.2.1 Global
3.6.2.2 North America
3.6.2.3 Europe
3.6.2.4 Asia

4 Global Nerve Repair And Regeneration Market (Page No. – 57)
4.1 Introduction
4.2 Regeneration Market, By Surgery
4.2.1 Direct Neurorrhaphy
4.2.1.1 Epineural Repair
4.2.1.2 Perineural Repair
4.2.1.3 Group Fascicular Repair
4.2.2 Nerve Grafting
4.2.2.1 Autografts
4.2.2.2 Allografts
4.2.2.3 Xenografts
4.2.3 Stem Cell Therapy
4.2.4 Neurostimulation/Neuromodulation Surgery
4.2.4.1 External Neurostimulation/Neuromodulation Surgery
4.2.4.2 Internal Neurostimulation/Neuromodulation Surgery
4.3 Regeneration Market, By Products
4.3.1 Nerve Repair By Biomaterials
4.3.1.1 Nerve Conduits
4.3.1.2 Nerve Protectors
4.3.1.3 Nerve Wraps
4.3.1.4 Nerve Connectors
4.3.2 Nerve Repair By Neurostimulation/ Neuromodulation
4.3.2.1 Internal Neurostimulation
4.3.2.1.1 Spinal Cord Stimulation
4.3.2.1.2 Deep Brain Stimulation
4.3.2.1.3 Sacral Nerve Stimulation
4.3.2.1.4 Vagus Nerve Stimulation
4.3.2.1.5 Gastric Electrical Stimulation
4.3.2.2 External Neurostimulation
4.3.2.2.1 Transcutaneous Electrical Nerve Stimulation
4.3.2.2.2 Transcranial Magnetic Stimulation

5 Geographic Analysis (Page No. – 115)
5.1 Introduction
5.2 North America
5.3 Europe
5.4 Asia
5.5 Rest Of The World

6 Competitive Landscape (Page No. – 148)
6.1 Introduction
6.2 Mergers & Acquisitions
6.3 Agreements, Partnerships, Collaborations & Joint Ventures
6.4 New Product Launch
6.5 Expansions
6.6 Approvals

7 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 158)
7.1 Alafair Biosciences, Inc.
7.2 Axogen, Inc.
7.3 Baxter International, Inc.
7.4 Biocontrol Medical
7.5 Boston Scientific Corporation
7.6 Cyberonics, Inc.
7.7 Integra Lifesciences Holdings Corp.
7.8 Medtronic, Inc.
7.9 Orthomed S.A.S.
7.10 Polyganics
7.11 Salumedica
7.12 St. Jude Medical
7.13 Stryker Corporation
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

Appendix (Page No. – 225)

List Of Tables (88 Tables)

Table 1 Global Nerve Repair & Regeneration Market, By Products, 2011-2018 ($Million)
Table 2 Global Regeneration Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 3 Global Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 4 Global Surgery Market Volume, By Geography, 2011-2018 (No. Of Surgeries)
Table 5 Global Direct Surgery Market Volume, By Type, 2011 - 2018 (No. Of Surgeries)
Table 6 Direct Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 7 Epineural Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 8 Perineural Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 9 Group Fascicular Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 10 Global Nerve Grafting Surgery Market Volume, By Type, 2011-2018 (No. Of Surgeries)
Table 11 Nerve Grafting Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 12 Autografts Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 13 Allografts Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 14 Xenografts Surgery Market Volume, By Geography, 2011-2018 (No. Of Surgeries)
Table 15 Stem Cell Therapy Market Volume, By Geography, 2011-2018 (No. Of Surgeries)
Table 16 Global Neurostimulation Market Volume, By Type, 2011 - 2018 (No. Of Surgeries)
Table 17 Neurostimulation Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 18 External Neurostimulation Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 19 Internal Neurostimulation Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 20 Global Nerve Repair & Regeneration Market, By Products, 2011-2018 ($Million)
Table 21 Regeneration Products Market, By Geography, 2011-2018 ($Million)
Table 22 Biomaterials Market, By Geography, 2011-2018 ($Million)
Table 23 Biomaterials Market, By Products, 2011 - 2018 ($Million)
Table 24 Nerve Conduits Market, By Geography, 2011 - 2018 ($Million)
Table 25 Nerve Protectors Market, By Geography, 2011 - 2018 ($Million)
Table 26 Nerve Wraps Market, By Geography, 2011 - 2018 ($Million)
Table 27 Nerve Connector Market, By Geography, 2011 - 2018 ($Million)
Table 28 Global Neurostimulation Products Market, By Type, 2011 - 2018 ($Million)
Table 29 Global Neurostimulation Products Volume Market, By Type, 2011 - 2018 (No. Of Units)
Table 30 Neurostimulation Products Market, By Geography, 2011 - 2018 ($Million)
Table 31 Global Internal Neurostimulation Market Revenue, By Type, 2011 - 2018 ($Million)
Table 32 Global Internal Neurostimulation Market Volume, By Type, 2011 - 2018 (No. Of Units)
Table 33 Internal Neurostimulation Market Revenue, By Geography, 2011 - 2018 ($Million)
Table 34 Internal Neurostimulation Market Volume, By Geography, 2011 - 2018 (No. Of Units)
Table 35 Spinal Cord Stimulation Market, By Geography, 2011-2018 ($Million)
Table 36 Deep Brain Stimulation Market, By Geography, 2011-2018 ($Million)
Table 37 Sacral Nerve Stimulation Market, By Geography, 2011-2018 ($Million)
Table 38 Vagus Nerve Stimulation Market, By Geography, 2011-2018 ($Million)
Table 39 Gastric Electrical Stimulation Market, By Geography, 2011-2018 ($Million)
Table 40 Global External Neurostimulation Nerve Repair & Regeneration Market, By Type, 2011 - 2018 ($Million)
Table 41 Global External Neurostimulation Market Volume, By Type, 2011 - 2018 (No. Of Units)
Table 42 External Neurostimulation Market, By Geography, 2011 - 2018 ($Million)
Table 43 External Neurostimulation Market Volume, By Geography, 2011 - 2018 (No. Of Units)
Table 44 Transcutaneous Electrical Nerve Stimulation Market, By Geography, 2011-2018 ($Million)
Table 45 Transcranial Magnetic Stimulation Market, By Geography, 2011– 2018 ($Million)
Table 46 Regeneration Products Market Revenue, By Geography, 2011 - 2018 ($Million)
Table 47 Regeneration Surgery Market Volume, By Geography, 2011 - 2018 (No. Of Surgeries)
Table 48 North America: Nerve Repair & Regeneration Market, By Products, 2011-2018 ($Million)
Table 49 North America: Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 50 North America: Direct Nerve Repair Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 51 North America: Nerve Graftingsurgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 52 North America: Xenografts Nerve Repair & Regeneration Market, By Products, 2011-2018 ($Million)
Table 53 North America: Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 54 North America: Neurostimulation Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 55 North America: Internal Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 56 North America: External Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 57 Europe: Nerve Repair & Regeneration Market, By Products, 2011 - 2018 ($Million)
Table 58 Europe: Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 59 Europe: Direct Nerve Repair Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 60 Europe: Nerve Grafting Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 61 Europe: Xenografts Nerve Repair & Regeneration Market, By Products, 2011-2018 ($Million)
Table 62 Europe: Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 63 Europe: Neurostimulation Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 64 Europe: Internal Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 65 Europe: External Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 66 Asia: Nerve Repair & Regeneration Market, By Products, 2011 - 2018 ($Million)
Table 67 Asia: Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 68 Asia: Direct Nerve Repair Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 69 Asia: Nerve Grafting Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 70 Asia: Xenografts Nerve Repair & Regeneration Market, By Products, 2011-2018 ($Million)
Table 71 Asia: Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 72 Asia: Neurostimulation Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 73 Asia: Internal Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 74 Asia: External Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 75 ROW: Nerve Repair & Regeneration Market, By Products, 2011 - 2018 ($Million)
Table 76 ROW: Surgery Market, By Volume, 2011 - 2018 (No. Of Surgeries)
Table 77 Row: Direct Nerve Repair Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 78 Row: Nerve Grafting Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 79 Row: Xenografts Nerve Repair & Regeneration Market, By Products, 2011-2018 ($Million)
Table 80 Row: Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 81 Row: Neurostimulation Surgery Market, By Volume, 2011-2018 (No. Of Surgeries)
Table 82 Row: Internal Neurostimulation Market, By Products, 2011-2018 ($Million)
Table 83 Row: External Neurostimulation Market,By Products, 2011-2018 ($Million)
Table 84 Mergers & Acquisitions (January 2011-March 2013)
Table 85 Agreements, Partnerships, Collaborations, Contracts, & Joint Ventures (April 2011-September 2012)
Table 86 New Product Launches (May 2011-September 2012)
Table 87 Expansions (May 2012-July 2012)
Table 88 Approvals (January 2011-June 2013)

List Of Figures (54 Figures)

Figure 1 Market Crackdown & Data Triangulation Methodology For Peripheral Nerve Repair Products Market
Figure 2 Market Crackdown & Data Triangulation Methodology For Peripheral Nerve Repair Surgery Market
Figure 3 Market Crackdown & Data Triangulation Methodology For Neuromodulation Market
Figure 4 Market Forecasting Model
Figure 5 Research Output-360o Validation
Figure 6 Regeneration Market, By Geography, 2011 - 2018 ($Million)
Figure 7 Regeneration Market Segmentation
Figure 8 Market Dynamics
Figure 9 Strategic Benchmarking: Product Expansion & Enhancement
Figure 10 Global Neuromodulation Products: Market Share Analysis, By Key Players, 2012
Figure 11 North America: Neuromodulation Products Market Share Analysis, By Key Players, 2012
Figure 12 Europe: Neuromodulation Products Market Share Analysis, By Key Players, 2012
Figure 13 Asia: Neuromodulation Products Market Share Analysis, By Key Players, 2012
Figure 14 Global Peripheral Nerve Repair & Regeneration Products: Market Share Analysis, By Key Players, 2012
Figure 15 North America: Peripheral Nerve Repair & Regeneration Products Market Share Analysis, By Key Players, 2012
Figure 16 Europe: Peripheral Nerve Repair & Regeneration Products Market Share Analysis, By Key Players, 2012
Figure 17 Asia: Peripheral Nerve Repair & Regeneration Products Market Share Analysis, By Key Players, 2012
Figure 18 Number Of Peripheral Nerve Repair Surgeries, By Type, 2011-2018 (Thousands)
Figure 19 Direct Nerve Repair Surgeries, By Type, 2013
Figure 20 Nerve Grafting Surgeries, By Type, 2013
Figure 21 Number Of Neuromodulation Surgeries, 2013 (Thousands) 74
Figure 22 Neuromodulation Market, Value - Volume Comparison, By Type, 2013
Figure 23 Lifecycle Of Neuromodulation Products
Figure 24 Opportunity Matrix: Neuromodulation Products, 2013
Figure 25 Nerve Repair Biomaterials Market Geographic & Product Analysis, 2013 ($Million)
Figure 26 Global Nerve Repair And Regeneration Market, By Geography, 2013
Figure 27 Geographic Reach Vs Product Portfolio Analysis: Key Players
Figure 28 Key Growth Strategies In Nerve Repair & Regeneration Market, 2011-2013
Figure 29 Axogen, Inc.: Total Revenue And R&D Expenses, 2009-2012 ($Million)
Figure 30 Axogen: Swot Analysis
Figure 31 Baxter International, Inc.: Total Revenue And R&D Expenses, 2009-2012 ($Billion)
Figure 32 Baxter International, Inc.: Geographic Revenue Mix, 2012
Figure 33 Baxter International, Inc.:Business Revenue Mix, 2012
Figure 34 Boston Scientific Corporation: Total Revenue And R&D Expenses, 2009-2012 ($Billion)
Figure 35 Boston Scientific Corporation: Geographic Revenue Mix, 2012
Figure 36 Boston Scientific Corporation: Business Revenue Mix, 2012
Figure 37 Boston Scientific Corporation: Swot Analysis
Figure 38 Cyberonics, Inc.: Total Revenue And R&D Expenses, 2010-2013 ($Million)
Figure 39 Cyberonics, Inc.: Geographic Revenue Mix, 2013
Figure 40 Integra Lifesciences Holding Corp.: Total Revenue And R&D Expenses, 2009-2012 ($Million)
Figure 41 Integra Lifesciences Holding Corp.: Geographic Revenue Mix, 2012
Figure 42 Integra Lifesciences Holding Corp.: Business Revenue Mix, 2012
Figure 43 Medtronic, Inc.: Total Revenue And R&D Expenses, 2009-2012 ($Billion)
Figure 44 Medtronic, Inc.: Geographic Revenue Mix, 2012
Figure 45 Medtronic, Inc.:Business Revenue Mix, 2012
Figure 46 Medtronic: Swot Analysis
Figure 47 St. Jude Medical, Inc.: Total Revenue And R&D Expenses, 2009-2012 ($Billion)
Figure 48 St. Jude Medical, Inc.: Geographic Revenue Mix, 2012
Figure 49 St. Jude Medical, Inc.: Business Revenue Mix, 2012
Figure 50 St Jude Medical: Swot Analysis
Figure 51 Stryker Corporation: Total Revenue And R&D Expenses, 2009-2012 ($Billion)
Figure 52 Stryker Corporation: Geographic Revenue Mix, 2012
Figure 53 Stryker Corporation: Business Revenue Mix, 2012
Figure 54 Stryker Corporation: Swot Analysis

★調査レポート[世界の神経修復・神経再生市場:異種移植片、神経調節、手術など] ( Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018 / BT 2105) 販売に関する免責事項
[世界の神経修復・神経再生市場:異種移植片、神経調節、手術など] ( Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018 / BT 2105) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆